With the help of Sarah Noonan, I've been able to present to you an introduction to an initiative initiative announced by President Obama earlier this week. Fortune Magazine featured the article, an editorial by the Multiple Myeloma Research Foundation's (MMRF) Kathy Giusti after accompanying the President for this groundbreaking announcement. Here's an excerpt: Critics may
I've been accumulating a wide variety of helpful information since the start of the start of the new year. Not enough to post about one by one, but I didn't want that to stop me from passing them along. Onyx (now a division of Amgen) has been working hard to expand FDA approval of Kyprolis.
Several of you have asked me to post the link from Thursday Morning's Cure Talks broadcast, featuring Italian myeloma specialist, Dr. Antonio Palumbo. It was a fascinating broadcast. Co-hosts from India and Florida, panelists from the East Coast and California, all questioning a physician in Torino, Italy: http://www.curetalks.com/event/rsvp/European-Perspective-on-Myeloma-Treatment-Strategies-with-Dr-Antonio-Palumbo/150/ Best I can tell the sound quality
Dr. Sagar Lonial, myeloma specialist and professor at Emory University's School of Medicine in Atlanta, recently wrote a helpful and easy to understand primer about how genetics fit in with today's fast advancing myeloma research and therapy. The lynchpin to fully understanding and implementing cutting edge genetic research: the Multiple Myeloma Research Foundation's (MMRF) ambitious
Thursday I ran the first of a three part series about three important cancer research initiatives that the MMRF announced last week. The first initiative hopes to build off momentum from the Multiple Myeloma Research Consortium’s (MMRC) drive to bank tissue from a large subset of multiple myeloma patients, collected in large part by 16